What is Crinetics Pharmaceuticals's price / book?

Crinetics Pharmaceuticals (CRNX) reported price / book of 3× in Q1 2026.

How has Crinetics Pharmaceuticals's price / book changed year-over-year?

Crinetics Pharmaceuticals's price / book increased by 19.3% year-over-year, from 2.5× to 3×.

What is the long-term trend for Crinetics Pharmaceuticals's price / book?

Over 5 years (2020 to 2025), Crinetics Pharmaceuticals's price / book has grown at a 2.3% compound annual growth rate (CAGR), from 4× to 4.5×.

What does price / book mean?

Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

Crinetics Pharmaceuticals CRNX Price / book

Price / book at other companies

Neurocrine BiosciencesNBIX

3.9×-0.5×

Corcept TherapeuticsCORT

6.7×-10.9×

Viking TherapeuticsVKTX

7.5×+4.3×

Catalyst PharmaceuticalCPRX

3×-0.7×

United TherapeuticsUTHR

4.4×+2.4×

Amneal Pharmaceuticals, Inc.AMRX

94.1×+93.1×

Other financials

Income statement

See full

Revenue$10.7M+2,873%

Gross profit$10.5M+2,818%

Operating income-$140.4M-26.0%

Net income-$127.8M-32.1%

EPS (diluted)-$1.23-18.3%

Balance sheet

See full

Cash & equivalents$115.1M+20.1%

Total debt$47.9M-5.8%

Total equity$1.3B+2.1%

Total assets$1.4B+2.9%

Cash flow

See full

Operating cash flow-$124.7M-41.0%

CapEx$820.0K-33.8%

Free cash flow-$125.5M-40.0%

Valuation

See full

Market cap$3.78B+21.9%

Enterprise value$3.71B+21.5%

P/S209.3×-3,875×

Profitability

See full

Gross margin150%-15.6pp

Operating margin-3,020.3%-1,463pp

Net margin-2,747.2%-1,328pp

FCF margin-2,321.7%-1,122pp

Returns & leverage

See full

Return on equity-39.2%+14.5pp

Debt / equity0×0.0×

Current ratio18.6×-3.9×

Where this comes from

Calculated from Crinetics Pharmaceuticals’s reported figures.

market cap/total stockholders equity=3×

Based on the most recent quarter.

The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Crinetics Pharmaceuticals's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Crinetics Pharmaceuticals's price / book?: Crinetics Pharmaceuticals (CRNX) reported price / book of 3× in Q1 2026.
How has Crinetics Pharmaceuticals's price / book changed year-over-year?: Crinetics Pharmaceuticals's price / book increased by 19.3% year-over-year, from 2.5× to 3×.
What is the long-term trend for Crinetics Pharmaceuticals's price / book?: Over 5 years (2020 to 2025), Crinetics Pharmaceuticals's price / book has grown at a 2.3% compound annual growth rate (CAGR), from 4× to 4.5×.
What does price / book mean?: Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.